ROSGQ (Rosetta Genomics) Total Assets: $6.21 Mil (As of Jun. 2017)


What is Rosetta Genomics Total Assets?

Rosetta Genomics ROSGQ -99.00% Total Assets is $6.21 Mil as of Jun. 2017.

Rosetta Genomics's Total Assets for the quarter that ended in Jun. 2017 was $6.21 Mil.

Total Assets is connected with ROA %. Rosetta Genomics's annualized ROA % for the quarter that ended in Jun. 2017 was -100.99%. Total Assets is also linked to Revenue through Asset Turnover. Rosetta Genomics's Asset Turnover for the quarter that ended in Jun. 2017 was 0.18.

Rosetta Genomics  (OTCPK:ROSGQ) Total Assets Explanation

Total Assets is connected with ROA %.

Rosetta Genomics's annualized ROA % for the quarter that ended in Jun. 2017 is

ROA %=Net Income (Q: Jun. 2017 )/( (Total Assets (Q: Dec. 2016 )+Total Assets (Q: Jun. 2017 ))/ count )
=-9.174/( (11.961+6.207)/ 2 )
=-9.174/9.084
=-100.99 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2017) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Rosetta Genomics's Asset Turnover for the quarter that ended in Jun. 2017 is

Asset Turnover
=Revenue (Q: Jun. 2017 )/( (Total Assets (Q: Dec. 2016 )+Total Assets (Q: Jun. 2017 ))/ count )
=1.608/( (11.961+6.207)/ 2 )
=1.608/9.084
=0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Rosetta Genomics Total Assets Related Terms

Rosetta Genomics Total Assets Historical Data

* Premium members only.

The historical data trend for Rosetta Genomics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rosetta Genomics Total Assets Chart

Rosetta Genomics Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.53 25.88 17.28 22.42 11.96

Rosetta Genomics Semi-Annual Data
Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.31 22.42 15.80 11.96 6.21

Rosetta Genomics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Rosetta Genomics's Total Assets for the fiscal year that ended in Dec. 2016 is calculated as

Total Assets=Total Equity (A: Dec. 2016 )+Total Liabilities (A: Dec. 2016 )
=4.417+7.544
=11.96

Rosetta Genomics's Total Assets for the quarter that ended in Jun. 2017 is calculated as

Total Assets=Total Equity (Q: Jun. 2017 )+Total Liabilities (Q: Jun. 2017 )
=1.099+5.108
=6.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $6.21 Mil mean?
Rosetta Genomics (ROSGQ) has a Total Assets of $6.21 Mil as of Jun. 2017. The total amount of assets as recorded on a company's balance sheet. View historical data on Rosetta Genomics and its competitors.
Is Rosetta Genomics' Total Assets too high?
Rosetta Genomics' current Total Assets is $6.21 Mil.
How does Rosetta Genomics' Total Assets compare to TEAR and IDTA?
Rosetta Genomics' Total Assets of $6.21 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Diagnostics & Research company?
A good Total Assets depends on the Medical Diagnostics & Research industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Rosetta Genomics and its competitors. Rosetta Genomics's current Total Assets is $6.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rosetta Genomics stock overvalued right now?
Rosetta Genomics (ROSGQ) has a current Total Assets of $6.21 Mil. The current Total Assets is $6.21 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Rosetta Genomics (ROSGQ), the current Total Assets is $6.21 Mil as of Jun. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rosetta Genomics Business Description

Address 10 Plaut Street, Science Park, Rehovot, ISR, 76706
Rosetta Genomics Ltd is an Israel based genomic diagnostics company operating globally. It is focused on research and development on diagnostics and therapeutics in the field of microRNAs. The firm markets and sells four diagnostic tests based on its microRNA technologies namely, RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer, mi-LUNG, mi-KIDNEY which is a microRNA-based kidney tumor classification test for pathology samples and RosettaGx Reveal which is a microRNA-based assay for the diagnosis of indeterminate thyroid fine-needle aspirate samples. Its revenues include Clinical testing revenues and Licensing revenues, of which Clinical testing revenue is maximum. The group generates its revenues mainly from diagnosing patient tissue.